John Harris Leamon

This inventor holds 44 USPTO granted patents and 48 published patent applications, plus 5 CIPO patents and 20 EPO patents, primarily in Nucleic Acid Amplification. Top assignees: Life Technologies Corporation, 454 Life Sciences Corporation, Cyvek, Inc.. Active years: 2007-2025.

USPTO Granted Patents = 44 (Patent Applications = 48)

% Patents Active = 90.9

CIPO Patents = 5

EPO Patents = 20 (Patent Applications = 19)

Average Co-Inventor Count = 4.6

ph-index = 17

Forward Citations = 3,366(Granted Patents)

Location History:

Clinton, CT (US) (2013)
Guilford, CT (US) (2007 - 2021)
Stonington, CT (US) (2015 - 2024)

Company Filing History:

28 out of 1,890

Life Technologies Corporation

patents

11 out of 31

454 Life Sciences Corporation

454 Lice Sciences Corporation

patent

5. 1 out of 128

Quantum-Si Incorporated

patents

6. 1 out of 643

Roche Molecular Systems, Inc.

patents

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

Nucleic Acid Amplification

Multiplex PCR

ChemFET Sensors

Bead Emulsion

Reaction Chambers

Integrated Sensor Arrays

Analyte Measurement

Fluid Pumping

Centrifuge Technology

PDMS Membranes

Nucleic Acid Sequencing

Large Scale FET Arrays

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12234452 - Scaffolded nucleic acid polymer particles and methods of making and using (2025-02-25),

2. 12146853 - Methods and apparatus including array of reaction chambers over array of chemFET sensors for measuring analytes (2024-11-19),

3. 12011716 - Peristaltic pumping of fluids and associated methods, systems, and devices (2024-06-18),

4. 11874250 - Integrated sensor arrays for biological and chemical analysis (2024-01-16),

5. 11851703 - Methods and compositions for multiplex PCR (2023-12-26),

6. 11530444 - Methods and apparatus for measuring analytes using large scale FET arrays (2022-12-20),

7. 11448613 - ChemFET sensor array including overlying array of wells (2022-09-20),

8. 10982274 - Bead emulsion nucleic acid amplification (2021-04-20),

9. 10837052 - Methods and compositions for multiplex PCR (2020-11-17),

10. 10829811 - Methods and compositions for multiplex PCR (2020-11-10),

11. 10781474 - Centrifuge with variable angle buckets and method for loading a device (2020-09-22),

12. 10612017 - Scaffolded nucleic acid polymer particles and methods of making and using (2020-04-07),

13. 10266881 - Methods and compositions for multiplex PCR (2019-04-23),

14. 10240192 - Bead emulsion nucleic acid amplification (2019-03-26),

15. 10209250 - PDMS membrane-confined nucleic acid and antibody/antigen-functionalized microlength tube capture elements, and systems employing them, and methods of their use (2019-02-19),

As a client, you can find the article about John Harris Leamon below:

Title: Innovator Spotlight: John Harris Leamon

Introduction: John Harris Leamon, a prolific inventor based in Guilford, CT (US), has made significant contributions in the field of biological and chemical analysis through his numerous patented inventions.

Latest Patents: John Harris Leamon's latest patents include groundbreaking innovations such as "Integrated sensor arrays for biological and chemical analysis" and "Methods and compositions for multiplex PCR". These inventions focus on enhancing signal quality in nucleic acid sequencing reactions and enabling selective amplification of target sequences associated with diseases like cancer.

Career Highlights: With an impressive total of 41 patents to his name, John Harris Leamon has demonstrated his expertise in developing advanced technologies for biological and chemical analysis. He has notably worked with renowned companies like Life Technologies Corporation and 454 Life Sciences Corporation, showcasing his ability to thrive in cutting-edge research and development environments.

Collaborations: Throughout his career, John Harris Leamon has collaborated with esteemed professionals in the field, including his coworkers Jonathan M Rothberg and Mark R Andersen. These collaborations have led to the successful implementation of innovative solutions in the realm of nucleic acid sequencing and multiplex PCR.

Conclusion: John Harris Leamon's groundbreaking inventions and prolific patent portfolio underscore his significant contributions to the field of biological and chemical analysis. His collaborations with industry peers and employers have further solidified his reputation as a visionary inventor at the forefront of innovation.